The Chicago Entrepreneur

Bristol Myers Squibb results beat expectations as newer drugs deliver growth

Bristol Myers Squibb Co. on Friday reported second-quarter results that topped analysts’ estimates as some of the company’s newer drugs began to hit their stride.

Previous post Charter’s stock could post best day in five years after earnings
Next post Hedge-fund giant Man says assets reach record levels